“But if you had to guess? Let’s say the Nobel committee told you to forward your hypothesis today, or they would never listen to you again,” Will pressed.
“That sounds like the Nobel committee all right,” Johansen laughed. “Since you are being very persistent, I will tell you my theory. Understand, however, I have no conclusive evidence to support this idea; it is only a theory.”
“No problem.”
“I speculate that you have a genetic mutation — passed down from Paul Foster via your paternal lineage — which is responsible for the unusual lymphocyte in your pictures. I have postulated for several years now that, theoretically, a skeleton key lymphocyte could exist.”
“Skeleton key lymphocyte?” Julie questioned.
“Let me explain: T cells and B cells are specific, meaning a single lymphocyte has receptors that can bind only to a particular antigen. Think of this as a lock and key system — a single key fits a single lock. Now, imagine a mutation where a lymphocyte could bind to a variety of antigens expressed by a variety of pathogens. Instead of being effective against only one specific type of pathogen, a skeleton key lymphocyte could mount a defense against many different pathogens — just as a skeleton key can work on many different locks. Such a mutation would bestow upon its owner an extremely efficient immune response.”
“How can we determine if Will has this skeleton key mutation?”
“I know only one way to do that my dear, and it’s the hard way. Research. Lots and lots of research,” Johansen laughed. “But let’s start with the DNA test to confirm Will’s ancestry first, shall we?”
“How long will that take?”
“I can draw the blood sample in the lab now, but the analysis will take some time. I should have a preliminary answer within a couple of days. I would also like to draw additional vials of blood to begin an analysis on that mystery lymphocyte of yours. Are you opposed to that?” Johansen asked.
Will looked at Julie.
“Were going to need some assurances from you and the university before we tread down that path,” she said.
“Of course,” Professor Johansen replied. Then he took Will’s hand between both of his and squeezed, while looking Will in the eyes. “Please understand, I might be a man of science, but I am also a man of conscience. I’m morally opposed to the patenting of genes. I maintain the belief that your genome is your property. I have no more right to patent it for my own personal gain than I do the right to pilfer the contents of your wallet. Vyrogen tried to exploit you, make you the Henrietta Lacks of our time, but I assure you that will never happen here. I sign a written contract with every research subject in my genealogy study, waiving any and all patent rights to genes discovered while conducting my research. The university doesn’t always like it, but I’ve made it a condition of my employment.”
Gene patents? Henrietta Lacks? He turned to Julie again. “What is he talking about, Julie?”
“Medical practitioners and medical researchers have always been joined at the hip, but with the advent of modern genetics, we’ve become strange bedfellows,” Julie said. “It all started in early 1950s with an American woman named Henrietta Lacks. She was diagnosed with an aggressive form of cervical cancer. She was treated at Johns Hopkins. For diagnostic purposes, her doctor ordered a tissue biopsy of her cervix. A scientist in the culture lab by the name of George Gey noticed that Lacks’ cancer cells did not die off in the culture dish like normal cells did. Instead, they survived and multiplied unfettered. He dubbed these resilient cells HeLa cells, borrowing the first two letters from Henrietta and Lacks. As a scientist, Gey realized that these immortal cells would be invaluable to the field of medical research, so he cultured a HeLa cell line for this express purpose. This did nothing of course to help cure poor Henrietta of her cancer, but it did lay the foundation for sixty years of ground-breaking research based on her cells.”
“How do you know all this?” Will asked.
“I’m an oncology researcher, Will. I’ve been using HeLa cells my entire career. Every man, woman and child on this planet owes Henrietta Lacks a debt of gratitude. Without HeLa cells, modern medicine would not be where it is today. Vaccine creation, cancer research, pharmaceutical drug development, our understanding of infectious diseases like HIV and influenza… all these things rely on the use of HeLa cells,” she said. Then, exhaling slowly, she added, “But there’s more to it than that. In recent years, Henrietta Lacks has become the poster child for biomedical exploitation.”
“Why?”
“Because the HeLa cell line was cultured, patented, and commercialized without her knowledge or consent. Moreover, her family was kept in the dark and never financially compensated or paid a royalty from the subsequent profits. I think the point Professor Johansen was making is that if your mutation turns out to be the miraculous discovery we all think it is, then you and Henrietta Lacks would be kindred spirits — genetically exceptional and thus exploited for both patent and profit.”
Will narrowed his eyes. “Are you saying that Vyrogen could patent my genes and make millions of dollars from my immunity mutation simply because they happened to stumble across it first?”
“Billions of dollars,” Johansen said, beating Julie to the punch. “And yes, the U.S. Patent and Trademark Office has been granting patents on genes since the Supreme Court case of Diamond v. Chakrabarty in 1980. A recent study estimated that approximately 20 percent of the human genome has already been patented. It is disgusting. Patent holders are granted a virtual monopoly on applications associated with their patented genes, a practice that not only undermines scientific freedom and the collegial exchange of information, but also jeopardizes each and every person’s right to have free access to and use of the information encoded in their own DNA.”
“So Vyrogen has already won,” Will said, his eyes cast down. “Once they patent my mutation, they control everything.”
“Not necessarily,” Johansen replied. Then with a sly grin he added, “I would never presume to tell you what to do in a scenario as extraordinary as yours. I can, however, tell you what I would do if our stations were reversed.”
“And what would you do?”
“I would publish my genome on the Internet, for the entire world to see. It would be my gift to humanity,” said Johansen.
“And, it would make life hell for Vyrogen,” Julie added. “If Dr. Johansen can identify the genes responsible for your mutation and make a public disclosure before Vyrogen, then you win and Vyrogen loses.”
Johansen nodded. “The irony of trying to sell something which is priceless is that one should never try to sell it to begin with.”
Will nodded, contemplating his words. “Thank you, Professor, for everything.”
“Don’t thank me yet. Were just starting this race,” said Johansen, shaking Will’s hand.
“You’ve done plenty already. You’ve given me hope.”
Johansen smiled and looked down, almost embarrassed. He liked Will Foster. It took great courage to do what he was doing, especially considering the ordeal he had been through with Vyrogen, and great courage was hard to find in people these days.
“This,” Johansen said, taking the diary off the table and handing it to Will, “should belong to you. I think you will find the story to be inspirational.”
“I couldn’t,” Will stammered.
“Don’t be ridiculous. The words on these pages are no more mine to possess than the information encoded in your DNA. I’m just along for the ride. Please, take it. Meet Kathryn Foster. Meet her husband, Paul, and their son, George. Know what it was like to be a Foster in 1665.”